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The following correction applies to all of the above articles and to the Authors' Correction published in the April 1998 issue of the Journal of :
In attempts to re-evaluate our previously reported data on inhibition of HIV-1 by intracellular single chain variable fragments (SFvs), some original data were not able to be located and some other data might not be fully consistent with certain previously published graphs. Therefore, we have now completed extensive new experimentation involving the anti-HIV-1 single chain variable fragments (SFvs), including Rev (D8), Integrase (IN33), and Reverse Transcriptase SFvs, described by our laboratories. In these repeat studies, the multiplicity of infections (mois) used in viral challenge studies were estimated by tissue culture infectious dose 50% (TCID 50 ) per target cell, calculated via a described technique (Techniques in HIV Research, Eds. Aldovini, A. and Walker, B., 1990) . The mois of viral input which led to complete or near complete protection of SUPT 1 T-cells transduced with the anti-HIV-1-SFvs varied between 0.00004 to 0.00002. These were somewhat lower than those described in the initial reports (utilizing HIV-1 NL4-3 ). Nevertheless, the levels of viral growth in control cultures, in the previously published reports and in the new studies, were very similar. Many of the new studies actually showed higher viral growth in control cultures, with complete viral suppression in the SFv-transduced cultures, as compared to the previously published data. As such, only the moi numbers seem to differ but not the robustness of protection against HIV-1 growth by these intracellular anti-HIV-1-SFvs. In addition, we have recently shown the specificity of post-integration inhibition of HIV-1 by the RevD8-SFv in latently infected cells (AIDS Res. & Human Retro. 14:1573 , 1998 . Binding studies for D8RevSFv against recombinant Rev protein were also repeated by ELISA and showed binding above the background and negative control levels. Intracellular specific binding was also demonstrated by another group utilizing our IN33SFv (PNAS 96:11723, 1999 
